Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06754228 · ClinicalTrials.gov registry record · NA

Acute Immune Modulation by Probiotic Strain

A NA study of Immune Surveillance, sponsored by Natural Immune Systems.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06754228 is a NA study of Immune Surveillance that is actively recruiting participants, run by Natural Immune Systems. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06754228, a NA study of Immune Surveillance, is actively recruiting participants, sponsored by Natural Immune Systems.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Clinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the probiotic on immune function when compared to a placebo.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Probiotic Agent

Study Locations (1)

Oregon

  • NIS Labs - Klamath Falls

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-11-13
Est. Completion 2025-12-15
Phase NA

Sponsor

Natural Immune Systems

17 total trials

What the Registry Record Tells You About NCT06754228

The ClinicalTrials.gov registry entry for NCT06754228 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Immune Surveillance appearing as the primary indexed condition, and to 1 intervention - of which Probiotic Agent is the first listed.

NCT06754228 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06754228 about?

NCT06754228 is a clinical study titled "Acute Immune Modulation by Probiotic Strain". Clinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Testing for immune stat...

What is the current status of trial NCT06754228?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-11-13. Estimated completion is 2025-12-15.

What conditions does trial NCT06754228 study?

This clinical trial studies the following conditions: Immune Surveillance.

What interventions are being tested in trial NCT06754228?

The interventions under investigation include: Probiotic Agent (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06754228?

This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06754228 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Immune Surveillance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.